diverting these proteins away from a major site of b-and g-secretase cleavage activity. In doing so, the AP4-mediated trafficking route may effectively confer protection against Ab production and thus reduce the risk of Alzheimer's disease. One prediction from this model is that defects in AP4 function may predispose people to Alzheimer's, and it will be of great interest to see if this turns out to be the case either in patients or in AP4-deficient animal models.
Given that the processing of APP down the amyloidogenic or non-amyloidogenic routes is dependent on the spatial and temporal coincidence of APP and its various processing proteases, it is clear that APP and secretase trafficking is critical for regulating the severity of APP breakdown to the toxic Ab peptide. In many ways, Alzheimer's disease can be considered as a disease of membrane trafficking. Recent years have seen the identification of a number of protein coats that directly and indirectly regulate sorting of APP and secretases between intracellular organelles [5, 6, 14] including: the GGA clathrin adaptors at the TGN; retromer and the associated sorting nexin SNX1 at endosomes [15] ; FE65 [16] and SNX17 [17] , which each bind to APP via an NPxY motif to regulate APP endocytosis and endosomal recycling, respectively; and the AP1 complex, which controls basolateral sorting of APP via a membrane-proximal tyrosine-containing sequence [18] ( Figure 1B) . Interestingly, while retromer and SNX17 each regulate an opposing pathway from that regulated by AP4, namely egress of APP from endosomes, they also appear to play a similar protective role in reducing APP processing to Ab, suggesting a highly complicated relationship between APP localisation and Ab production. The work by Burgos et al. [8] now places AP4 alongside these other intracellular trafficking proteins as an important new player in the Alzheimer's story, and dissection of the relative contributions of these different pathways to APP processing and Alzheimer's disease is developing as a critical field of investigation. Most proteins that are secreted into the extracellular space utilize the conventional route, in which proteins are directed through the endoplasmic reticulum (ER) and Golgi prior to their release. A common feature of proteins secreted through this pathway is the presence of a signal peptide that is recognized by the signal-recognition particle for transport into the ER once it has been synthesized by the ribosome. After reaching the ER lumen, signal peptides are proteolytically cleaved and the newly synthesized proteins are further trafficked along the secretory pathway to the Golgi apparatus by coat protein II (COPII)-coated vesicles that form at specialized ER exit sites ( Figure 1, pathway A) . In the Golgi and trans-Golgi network, the proteins are modified and processed before they are delivered to the extracellular environment in a regulated or constitutive manner. While this conventional secretory pathway is well characterized, both lower and higher eukaryotes contain certain proteins that are secreted even though they lack signal peptides. At least two classes of proteins utilize non-conventional transport to the cell surface, a process referred to as unconventional protein secretion: the first class harbors a signal-peptide sequence but reaches the cell surface in a COPII-and Golgi-independent manner [1] ; and the second is secreted independently of both the ER and Golgi. Interestingly, proteins following the latter unconventional secretory pathway lack the signal peptide required for ER import and are often cytosolic or nuclear signaling molecules. Four mechanisms for secretion of such soluble cytosolic proteins have previously been suggested: one non-vesicular, direct pathway, and three slightly different vesicular pathways [2] . Despite research conducted during the 20 years that have passed since the discovery of the first cytosolic proteins that follow an unconventional route for secretion [3, 4] , a clear consensus for a common mechanism has not been obtained. Through the use of yeast genetics, two new studies [5, 6] now show that the autophagic machinery participates in the packaging and delivery of the soluble yeast protein acyl-Coenzyme A-binding protein Acb1 to the cell surface. This novel autophagic secretory process -exophagy -represents the fourth vesicular pathway for secretion of cytosolic proteins lacking signal peptides.
Autophagy is best known as a transport pathway in which cytosolic proteins are packaged into specialized vesicles and delivered to Proteins secreted through the conventional secretory pathway contain an ER signal peptide, which is recognized by the signal recognition particle immediately after synthesis, triggering transport of the protein into the ER followed by signal peptide cleavage and trafficking to the Golgi (pathway A). Proteins secreted through the conventional route are dependent on the COPII coat protein Sec23, the Arf guanine nucleotide exchange factor Sec7, as well as Sec1, a SNARE-binding protein important for vesicle membrane fusion. The recent work [5, 6] reports that secretion of Acb1 is initiated through starvation and depends on the basal autophagic machinery. The sequestration of the cytosolic material to be degraded is initiated by the formation of the isolation membrane, which through expansion and closure leads to the formation of the characteristic double-membrane autophagosome. The basal autophagic machinery, encoded by several autophagy-related (Atg) genes, is responsible for the process initiating this pathway. Upon starvation, Acb1 is also packaged into autophagic vesicles, but, at a critical point in the autophagic pathway, Acb1-containing vesicles are discriminated from the degradative autophagic vesicles and are not transported to the vacuole but instead to the plasma membrane (pathway B). The trafficking of Acb1 to the extracellular space is dependent on the peroxisomal formation of Acyl-CoA, which directly binds to Acb1. It is plausible that Acyl-CoA is part of the redirection signal required for Acb1 secretion. Acb1 might be secreted when the fusion product of autophagosomes and multivesicular bodies (MVBs) -amphisomes -fuse with the plasma membrane. An alternative possibility is that Acb1-positive vesicles directly fuse with the plasma membrane to release its content.
the vacuole/lysosome for degradation [7, 8] In the two recent papers describing unconventional protein secretion through the autophagic machinery [5, 6] , the encapsulation of D. discoideum prespore cells was used as an assay for the unconventional secretion of an SDF-2-like factor from the yeasts Pichia pastoris and Saccharomyces cerevisiae. Interestingly, secretion of SDF-2 activity was blocked following deletion of several autophagy-related (Atg) genes encoding proteins such as those acting directly downstream from the TOR serine/threonine kinase and involved in autophagy initiation (Atg1 and Atg17) [6] , as well as components of the Vps34/Beclin complex (Atg6) [6] . Furthermore, deletion of the genes encoding the ubiquitin-like proteins Atg12 and Atg8/LC3 [5, 6] , and factors involved in the conjugation of these proteins (Atg5 and Atg7) [5] , also prevented SDF-2 release and encapsulation. Likewise, no SDF-2-like activity was seen upon deletion of the multi-spanning membrane protein Atg9 [6] , which is recruited to the preautophagosomal structure through Atg17 and Atg1. A similar effect was seen following loss of Atg11 [6] , which associates with the preautophagosomal structure in an actin-dependent manner and is required for recruitment of Atg9 to this structure. Altogether, these experiments suggest the existence of an intriguing vesicular survival program in yeast that utilizes the same machinery for both secretion and degradation of cellular components (Figure 1, pathway B) .
Acb1 lacks the signal peptide for transport through the ER, and Duran et al. [5] used yeast genetics to show that secretion of Acb1 is indeed not dependent on the machinery involved in conventional protein secretion, i.e. Sec23 (COPII component), Sec7 (guanine nucleotide exchange factor for Arf GTPases) and Sec1 (SNARE-binding protein important for vesicle membrane fusion). It has previously been shown that loss of the SNARE regulator Sec18/NSF impairs most intercompartmental protein transport events in the secretory pathway, such as from the ER to Golgi, through the Golgi, and from the Golgi to the plasma membrane [9] . Given that the temperature-sensitive secretory sec18-1 mutant only showed SDF-2-like activity at the permissive temperature, Duran et al. [5] suggest that a SNARE-dependent fusion event must be required for Acb1 secretion, as supported by the finding that the plasma membrane t-SNARE Sso1 is also essential for secretion of SDF-2-like activity [5] . Similarly, Manjithaya et al. [6] showed indirectly that SNAREs are involved in Acb1 secretion from P. pastoris cells because interference with the localization of the t-SNARE blocked SDF-2-like secretion.
The autophagic machinery in yeast cells grown in the absence of a nitrogen source is responsible both for the degradation of cellular components that will be utilized as new building blocks and for the generation of energy, given the new findings showing that this machinery is used to secrete Acb1. So, how can the cells discriminate between the autophagic content to be degraded and that destined for secretion? Obviously, in order to keep the Acb1 protein intact until secretion, the Acb1-containing vesicles cannot be targeted for vacuolar fusion as this will lead to their degradation. In line with this idea, deletion of VAM3, which encodes a component of the SNARE complex involved in the fusion between autophagic vesicles and the vacuole, had no effect on the secretion of SDF-2-like activity [5, 6] . Secretion of Acb1 also occurred independently of vacuolar hydrolases [6] . Likewise, sporulation was not affected in cells lacking the small GTPase Ypt7, which is also required for vacuolar fusion [5, 6] . Indeed, Acb1-containing autophagic vesicles do not fuse with the vacuole but leave Acb1 intact for secretion.
But how then do the Acb1-containing secretory autophagic vesicles reach the plasma membrane instead of the vacuole? A reasonable explanation could be that the Acb1-positive autophagic vesicles contain some sort of 'redirection signature' that blocks vacuolar fusion or promotes fusion with the plasma membrane. Curiously, the mammalian and D. discoideum homologues of Acb1 bind medium-and long-chained fatty acyl-CoA, and the synthesis of this lipid in peroxisomes is required for the secretion of SDF-2-like activity [6] . It is plausible that insertion of a lipid product, such as acyl-CoA, into the autophagic membrane can alter the composition of, for example, the vesicle coat in a manner that could serve to redirect the Acb1 vesicle to the plasma membrane. It remains to be established what coat proteins are involved and whether this process is controlled by acyl-CoA. In this respect, it would appear very attractive to perform a sporulation bioassay such as that carried out by Duran et al. [5] and Manjithaya et al. [6] , using a carefully selected set of strains from the yeast deletion collection [10] , as this most likely will provide the ultimate insight into the requirements for Acb1 secretion. One line of evidence reported by Duran et al. [5] that suggests that the Acb1-containing vesicles carry some unique features not present on degradative autophagic vesicles is the requirement of the t-SNARE Tlg2 and the Rab GTPase Ypt6 for Acb1 secretion. It would be interesting to study whether these particular vesicular 'tags' have anything to do with acyl-CoA.
To date, no consensus model for the origin of the isolation membrane in mammals has been reached, although endosomes, mitochondria, the ER, and the Golgi have all been suggested as possible membrane sources (reviewed in [11] ). Thus, the possibility exists that autophagosomes
